Cargando…
CD96 as a Potential Diagnostic Biomarker and New Target for Skin Cutaneous Melanoma
Skin cutaneous melanoma has high morbidity and mortality. Identification of reliable and quantitative melanoma biomarkers could facilitate an early diagnosis and improve survival and morbidity rates. CD96 has a significant role in adjusting immune function. Although the abnormal expression of CD96 h...
Autores principales: | Zhou, Wangying, Cai, Xiaobin, Liu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377941/ https://www.ncbi.nlm.nih.gov/pubmed/36043142 http://dx.doi.org/10.1155/2022/6409376 |
Ejemplares similares
-
Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma
por: Zhou, Xuezhi, et al.
Publicado: (2022) -
Identification of CD38 as a potential biomarker in skin cutaneous melanoma using bioinformatics analysis
por: Wang, Xianwang, et al.
Publicado: (2020) -
New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation
por: Zhou, Sitong, et al.
Publicado: (2021) -
CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021) -
Identification of Potential Prognostic Biomarkers Associated With Cancerometastasis in Skin Cutaneous Melanoma
por: Li, Yang, et al.
Publicado: (2021)